TAE Technologies is committed to creating a sustainable future for us all. We began our research into fusion energy nearly 20 years ago, and built our company with commercialization in mind. Our solution is clean, compact, affordable – and safe in every way. In short: Friendly Fusion.
Dispatches from TAE Technologies President, CTO and technology co-founder, Michl Binderbauer, and a behind the scenes look into our research. Learn more about our latest achievement in merging and colliding field-reverse configurations (FRCs) here.
June 4, 2020
The Road Less Traveled: TAE CEO Michl Binderbauer is profiled in Nautilus, discussing the benefits of the company’s approach to fusion energy.
June 1, 2020
TAE Life Sciences secures $30M in initial B round to accelerate development of unique boron delivery drugs for novel cancer treatment, boron neutron capture therapy (BNCT).
January 6, 2020
The Future Looks Bright: CEO Michl Binderbauer reflects on the last 20 years of TAE Technologies and what the new decade holds for fusion research and more.
December 4, 2019
In our pursuit of fusion energy, we’ve published many significant research reports and papers in peer-reviewed journals. Search over 150 papers, including experimental results and theoretical science, in our research library.
Gleaning data from a hot ball of nothing that lasts for much, much less than the blink of an eye requires a lot of clever testing tools.
